Navigation Links
InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs

RESEARCH TRIANGLE PARK, N.C., March 6 /PRNewswire/ -- InnerPulse, Inc., a privately held company with a disruptive technology for the treatment of abnormal heart rhythms, announced the appointment of Elsa Abruzzo to the newly formed position of Vice-President of Regulatory and Quality Affairs. Ms. Abruzzo has more than 18 years of experience in the medical device industry including cardiac devices, such as heart valves, neurovascular embolic devices, and biomaterials.

Ms. Abruzzo, 40, most recently served as Vice-President Regulatory and Clinical Affairs with AtriCure, Inc., a manufacturer of cardiac ablation devices. Prior to that Elsa was with Percutaneous Valve Technologies, Inc. (PVT) where she served as head of regulatory and clinical affairs for a breakthrough percutaneous aortic valve technology. Prior to PVT, Elsa spent 10 years with CryoLife, Inc. (biomaterials, tissue heart valves and vascular grafts) and Cordis Johnson and Johnson (vascular devices), all in regulatory and quality affairs.

"We are delighted to have someone with Elsa's extensive experience join our executive team at this important juncture of the Company's evolution. She will have a key leadership role as we initiate our clinical studies and move closer to gaining regulatory approval of our novel defibrillator technology. Her experience in leading several technologies successfully through the regulatory approval process over the past 18 years will provide great value as the Company begins our clinical trials," said InnerPulse President and Chief Executive Officer Daniel A. Pelak.

Elsa is a graduate of the University of Miami with a degree in Industrial and Manufacturing Engineering.

About InnerPulse, Inc.

Founded in 2003, InnerPulse is a privately held, early-stage company pioneering a novel technology for those patients who have cardiac rhythm disorders. More information is available at

Contact: Benny Ward, V.P. & C.F.O Len Hall (media)

InnerPulse, Inc. Allen & Caron Inc

919 287 4111 949 474 4300

SOURCE InnerPulse, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Ventas Appoints James D. Shelton and Robert D. Reed to Board
2. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
3. China Sky One Medical, Inc. Appoints Four Independent Board Members
4. Stiefel Laboratories, Inc. Appoints New President
5. Asthma Foundation Appoints Award-Winning Scholar to Top Policy Position
6. New Jersey Hospital Association Names New Chairman, Appoints Board Officers and New Members
7. Belden Appoints Mary S. McLeod of Pfizer Inc. to Board of Directors
8. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
9. CryoCath Appoints New Chief Financial Officer
10. Ceremed Appoints Vice President for Sales and Business Development
11. ScienceBased Health Appoints Anne L. Coleman, MD, PhD to Scientific Advisory Board
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: